Differences in location of cerebral white matter hyperintensities in children and adults living with a treated HIV infection: A retrospective cohort comparison

Cerebral white matter hyperintensities (WMH) persist in children and adults living with HIV, despite effective combination antiretroviral therapy (cART). As age and principal routes of transmission differ between children (perinatally) and adults (behaviorally), comparing the characteristics and determinants of WMH between these populations may increase our understanding of the pathophysiology of WMH. From separate cohorts of 31 children (NOVICE) and 74 adults (AGEhIV), we cross-sectionally assessed total WMH volume and number of WMH per location (periventricular vs. deep) using fluid-attenuated inversion recovery (FLAIR) MRI images. WMH were either periventricular when within 10mm of the lateral ventricles, or deep otherwise. We assessed patient- or HIV-related determinants of total WMH volume (adjusted for intracranial volume) and location of WMH using logistic regression, while stratifying on children and adults. At enrollment, median age of participants was 13.8 years (IQR 11.4–15.9) for children and 53.4 years (IQR 48.3–60.8) for adults and 27/31 children (87%) and 74/74 adults (100%) had an HIV RNA viral load <200 copies/mL. WMH were present in 16/27 (52%) children and 74/74 adults (100%). The prevalence of deep WMH was not different between groups, (16/16 [100%] in children vs. 71/74 [96%] in adults, p = 0,999), yet periventricular WMH were more prevalent in adults (74/74 [100%]) compared to children (9/16; 56%) (p<0.001). Median WMH volume was higher in adults compared to children (1182 mm3 [425–2617] vs. 109 mm3 [61.7–625], p<0.001). In children, boys were more likely to have deep WMH compared to girls. In adults, older age was associated with higher total WMH volume, and age, hypertension and lower CD4+ T-lymphocyte nadir with a higher number of periventricular WMH. Our findings suggest that the location of WMH differs between children and adults living with HIV, hinting at a different underlying pathogenesis.

[1]  G. Birbeck,et al.  Brain Magnetic Resonance Imaging Findings Associated With Cognitive Impairment in Children and Adolescents With Human Immunodeficiency Virus in Zambia. , 2020, Pediatric neurology.

[2]  Catherine Lebel,et al.  The development of brain white matter microstructure , 2018, NeuroImage.

[3]  D. Sharp,et al.  Clinical research cerebral MRI findings in HIV-positive subjects and appropriate controls , 2018, AIDS (London).

[4]  Jeffery R. Alger,et al.  HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition , 2018, AIDS.

[5]  D. Sharp,et al.  No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) Project , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Tubiana,et al.  Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  C. Jack,et al.  Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly , 2018, Neurology.

[8]  S. Daniels,et al.  Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents , 2017, Pediatrics.

[9]  Owen Carmichael,et al.  White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV , 2017, Journal of NeuroVirology.

[10]  D. Sharp,et al.  White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy , 2016, AIDS.

[11]  Sander Greenland,et al.  Sparse data bias: a problem hiding in plain sight , 2016, British Medical Journal.

[12]  P. Reiss,et al.  Cerebral injury in perinatally HIV-infected children compared to matched healthy controls , 2016, Neurology.

[13]  D. Sharp,et al.  White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment , 2016, AIDS.

[14]  B. Gelman.  Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered , 2015, Current HIV/AIDS Reports.

[15]  P. Reiss,et al.  Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  P. Reiss,et al.  Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  S. Andronikou,et al.  White Matter Signal Abnormalities in Children With Suspected HIV-related Neurologic Disease on Early Combination Antiretroviral Therapy , 2014, The Pediatric infectious disease journal.

[18]  L. Haddow,et al.  Cross-sectional study of unexplained white matter lesions in HIV positive individuals undergoing brain magnetic resonance imaging. , 2014, AIDS patient care and STDs.

[19]  A. Ünalp,et al.  Childhood headaches and brain magnetic resonance imaging findings. , 2014, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[20]  Benjamin S. Aribisala,et al.  Morphologic, Distributional, Volumetric, and Intensity Characterization of Periventricular Hyperintensities , 2014, American Journal of Neuroradiology.

[21]  James J. Goedert,et al.  Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada , 2013, PloS one.

[22]  Dan J Stein,et al.  Systematic review of neuroimaging studies in vertically transmitted HIV positive children and adolescents , 2013, Metabolic Brain Disease.

[23]  K. Kallianpur,et al.  Poorer neuropsychological performance increases risk for social services among HIV-infected individuals. , 2013, Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health.

[24]  J. Bale,et al.  White matter lesions in children and adolescents with migraine. , 2013, Pediatric neurology.

[25]  R. Laranjeira,et al.  Butyrylcholinesterase Genetic Variants: Association with Cocaine Dependence and Related Phenotypes , 2013, PloS one.

[26]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[27]  Sander Greenland,et al.  Bayesian regression in SAS software. , 2013, International journal of epidemiology.

[28]  M. Boivin,et al.  Neurodevelopment in perinatally HIV-infected children: a concern for adolescence , 2013, Journal of the International AIDS Society.

[29]  P. Nederkoorn,et al.  Cerebral small-vessel disease and progression of brain atrophy , 2012, Neurology.

[30]  N. Bargalló,et al.  Deep versus Periventricular White Matter Lesions and Cognitive Function in a Community Sample of Middle-Aged Participants , 2012, Journal of the International Neuropsychological Society.

[31]  V. Valcour,et al.  Impact of HIV and aging on neuropsychological function , 2012, Journal of NeuroVirology.

[32]  Ellen Woo,et al.  Longitudinal Change in Cognitive Function and Medication Adherence in HIV-Infected Adults , 2011, AIDS and Behavior.

[33]  P. Reiss,et al.  HIV-1 infection and cognitive impairment in the cART era: a review. , 2011, AIDS.

[34]  L. Pantoni.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[35]  J. Bell,et al.  The Neuropathology of HIV/AIDS , 2008, International review of psychiatry.

[36]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[37]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[38]  K. Levin.  Study design III: Cross-sectional studies , 2006, Evidence-Based Dentistry.

[39]  Francisco González-Scarano,et al.  The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.